Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Valerio

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Prostate Cancer and Prostatic Diseases|January 20, 2023
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
European Urology|November 5, 2013
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?Hitendra R H Patel, Yannick Cerantola, Massimo Valerio, et al.
European Urology Focus|June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery GuidelinesJudith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2024
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancerAndrea Mari, Anna Cadenar, Sofia Giudici, et al.
BJU International|May 18, 2018
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculatorGiorgio Gandaglia, Roderick C N van den Bergh, Derya Tilki, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology|April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node DissectionGiorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
European Urology|September 25, 2019
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Prostate Cancer and Prostatic Diseases|January 20, 2023
Correction to: Overdiagnosis and stage migration of ISUP 2 disease due to mpMRI-targeted biopsy: facts or fictionsAlberto Martini, Alae Touzani, Elio Mazzone, et al.
European Urology|November 5, 2013
Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?Hitendra R H Patel, Yannick Cerantola, Massimo Valerio, et al.
European Urology Focus|June 30, 2022
Enhancing Recovery After Major Bladder Cancer Surgery: Comprehensive Review and Assessment of Application of the Enhanced Recovery After Surgery GuidelinesJudith Stangl-Kremser, Luca Lambertini, Fabrizio Di Maida, et al.
Prostate Cancer and Prostatic Diseases|May 31, 2024
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancerAndrea Mari, Anna Cadenar, Sofia Giudici, et al.
BJU International|May 18, 2018
How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculatorGiorgio Gandaglia, Roderick C N van den Bergh, Derya Tilki, et al.
Therapeutic Advances in Medical Oncology|March 11, 2022
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art reviewIsabel Heidegger, Claudia Kesch, Alexander Kretschmer, et al.
European Urology|April 10, 2020
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node DissectionGiorgio Gandaglia, Alberto Martini, Guillaume Ploussard, et al.
European Urology Oncology|September 16, 2020
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic ReviewGiancarlo Marra, Massimo Valerio, Isabel Heidegger, et al.
European Urology|September 25, 2019
The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical ProstatectomyGiorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al.
Current Opinion in Urology|November 23, 2021
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidenceCharles Laine, Giorgio Gandaglia, Massimo Valerio, et al.
Pageof 18